These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 25012132)

  • 1. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
    Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy.
    Deliyanti D; Miller AG; Tan G; Binger KJ; Samson AL; Wilkinson-Berka JL
    Hypertension; 2012 Mar; 59(3):607-13. PubMed ID: 22275532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low birth weight in response to salt restriction during pregnancy is not due to alterations in uterine-placental blood flow or the placental and peripheral renin-angiotensin system.
    Leandro SM; Furukawa LN; Shimizu MH; Casarini DE; Seguro AC; Patriarca G; Coelho MS; Dolnikoff MS; Heimann JC
    Physiol Behav; 2008 Sep; 95(1-2):145-51. PubMed ID: 18572207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the Nuclear Receptor RORγ and Interleukin-17A Suppresses Neovascular Retinopathy: Involvement of Immunocompetent Microglia.
    Talia DM; Deliyanti D; Agrotis A; Wilkinson-Berka JL
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1186-96. PubMed ID: 27055905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal neovascularization is prevented by blockade of the renin-angiotensin system.
    Moravski CJ; Kelly DJ; Cooper ME; Gilbert RE; Bertram JF; Shahinfar S; Skinner SL; Wilkinson-Berka JL
    Hypertension; 2000 Dec; 36(6):1099-104. PubMed ID: 11116132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II and aldosterone activate retinal microglia.
    Rana I; Suphapimol V; Jerome JR; Talia DM; Deliyanti D; Wilkinson-Berka JL
    Exp Eye Res; 2020 Feb; 191():107902. PubMed ID: 31884019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina.
    Tan SM; Deliyanti D; Figgett WA; Talia DM; de Haan JB; Wilkinson-Berka JL
    Exp Eye Res; 2015 Jul; 136():1-8. PubMed ID: 25912997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PGE(2)-EP4 receptor is necessary for stimulation of the renin-angiotensin-aldosterone system in response to low dietary salt intake in vivo.
    Pöschke A; Kern N; Maruyama T; Pavenstädt H; Narumiya S; Jensen BL; Nüsing RM
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1435-42. PubMed ID: 22993066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure.
    Mori T; Kurumazuka D; Matsumoto C; Shirakawa H; Kimura S; Kitada K; Kobayashi K; Matsuda H; Hayashi T; Kitaura Y; Matsumura Y
    Eur J Pharmacol; 2009 Nov; 623(1-3):84-8. PubMed ID: 19766104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vasoneuronal effects of AT1 receptor blockade in a rat model of retinopathy of prematurity.
    Hatzopoulos KM; Vessey KA; Wilkinson-Berka JL; Fletcher EL
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3957-70. PubMed ID: 24894399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
    Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG
    Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
    Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
    Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy.
    Deliyanti D; Lee JY; Petratos S; Meyer CJ; Ward KW; Wilkinson-Berka JL; de Haan JB
    Clin Sci (Lond); 2016 Aug; 130(15):1375-87. PubMed ID: 27005782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-2 Injures the Blood-Retinal Barrier and Macroglial Müller Cells: Interactions with Angiotensin II, Aldosterone, and NADPH Oxidase.
    Alrashdi SF; Deliyanti D; Talia DM; Wilkinson-Berka JL
    Am J Pathol; 2018 Mar; 188(3):805-817. PubMed ID: 29248456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Emmett N; Socci RR; Eatman D; Fridie IL
    Clin Exp Hypertens; 2005 May; 27(4):355-67. PubMed ID: 15921072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
    Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM
    Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
    Bovée DM; Uijl E; Severs D; Rubio-Beltrán E; van Veghel R; Maassen van den Brink A; Joles JA; Zietse R; Cuevas CA; Danser AHJ; Hoorn EJ
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F654-F668. PubMed ID: 33586496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Müller cell ablation.
    Shen W; Lee SR; Araujo J; Chung SH; Zhu L; Gillies MC
    Glia; 2014 Jul; 62(7):1110-24. PubMed ID: 24687761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.